MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $20,973,750 | -32.4% | 6,375,000 | -15.6% | 0.28% | -38.0% |
| Q1 2023 | $31,030,500 | -29.9% | 7,550,000 | 0.0% | 0.46% | -30.4% |
| Q4 2022 | $44,243,000 | -13.3% | 7,550,000 | 0.0% | 0.66% | -29.9% |
| Q3 2022 | $51,038,000 | +46.3% | 7,550,000 | 0.0% | 0.94% | +36.9% |
| Q2 2022 | $34,881,000 | +28.6% | 7,550,000 | +11.0% | 0.69% | +39.2% |
| Q1 2022 | $27,132,000 | -35.9% | 6,800,000 | 0.0% | 0.50% | -31.2% |
| Q4 2021 | $42,296,000 | -34.0% | 6,800,000 | 0.0% | 0.72% | -28.5% |
| Q3 2021 | $64,124,000 | -30.6% | 6,800,000 | 0.0% | 1.01% | -37.3% |
| Q2 2021 | $92,344,000 | -16.1% | 6,800,000 | 0.0% | 1.61% | -15.5% |
| Q1 2021 | $110,024,000 | -39.2% | 6,800,000 | 0.0% | 1.90% | -39.0% |
| Q4 2020 | $180,948,000 | +42.9% | 6,800,000 | 0.0% | 3.12% | +73.2% |
| Q3 2020 | $126,616,000 | -16.8% | 6,800,000 | +4.6% | 1.80% | -40.2% |
| Q2 2020 | $152,100,000 | – | 6,500,000 | – | 3.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $4,564,000 | 3.47% |
| NEA Management Company, LLC | 11,963,649 | $68,552,000 | 3.24% |
| Sarissa Capital Management LP | 3,750,000 | $21,487,000 | 1.78% |
| VHCP Management III, LLC | 1,561,389 | $8,947,000 | 1.78% |
| VHCP Management II, LLC | 922,514 | $5,286,000 | 1.39% |
| Ghost Tree Capital, LLC | 800,000 | $4,584,000 | 0.87% |
| BVF INC/IL | 1,180,553 | $6,765,000 | 0.51% |
| Sio Capital Management, LLC | 166,250 | $953,000 | 0.23% |
| Rock Springs Capital Management LP | 1,233,000 | $7,065,000 | 0.22% |
| DAFNA Capital Management LLC | 108,463 | $621,000 | 0.21% |